![Carl Gordon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carl Gordon
Chairman at
COMPASS THERAPEUTICS, INC.
Net worth: 52 868 $ as of 31/07/2026
Profile
Carl Lee Gordon is the founder of OrbiMed Advisors LLC, founded in 1989, serving as Managing Partner since 2018.
Current jobs include Chairman at Compass Therapeutics, Inc. since 2019; Director at Sapphire Therapeutics, Inc., Amnis Corp.
since 2008, Singulex, Inc. since 2007, Adimab LLC, Agensys, Inc., X4 Pharmaceuticals (Austria) GmbH, Gemini Therapeutics Sub, Inc., Emendo Biotherapeutics, Inc., Kumquat Biosciences, Inc., Frontera Therapeutics (HK) Ltd., XinThera, Inc., Gwynant Therapeutics, Inc., Stratus Therapeutics, Inc., Electra Therapeutics, Inc., Star OpCo, Inc., Avenzo Therapeutics, Inc. as Independent Director, The New York City Investment Fund Manager, Inc. as Advisor, and Aragon Pharmaceuticals, Inc. as Principal.
Director roles also include Lomond Therapeutics Holdings, Inc. since 2024, Scribe Therapeutics, Inc. and Blossomhill Therapeutics, Inc. since 2021, OrbiMed Advisors Private Equity since 1995 as Managing Partner, and others.
Former jobs include Independent Director at MBX Biosciences, Inc. (2020–2025), Arrivent BioPharma, Inc. (2022–2025), Selecta Biosciences, Inc. (2010–2017), Arsanis, Inc. (2010–2019), Alector, Inc. (2013–2019), Oric Pharmaceuticals, Inc. (2015–2021), and others.
Director roles were held at BioCryst Pharmaceuticals, Inc. (2004–2007),.
Amarin Corp.
Plc (2012–2013), Arius Research, Inc. (2006–2009), Acceleron Pharma, Inc. (2006–2013), Complete Genomics, Inc. (2011–2012), Pacira Biosciences, Inc. (2011), Theseus Pharmaceuticals, Inc. (2018–2024), Kinnate Biopharma, Inc. (2019–2024), Gemini Therapeutics, Inc. (2016–2022), Prevail Therapeutics, Inc. (2017–2021), Terns Pharmaceuticals, Inc. (2018–2025), Passage Bio, Inc. (2018–2020), and others.
Education includes a doctorate from Massachusetts Institute of Technology conferred in 1993 and an undergraduate degree from Harvard College conferred in 1987.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 04/06/2025 | 5,250 ( 0.03% ) | 52 868 $ | 31/07/2026 | |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/07/2026 | |
| 06/08/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Carl Gordon active positions
| Companies | Position | Start |
|---|---|---|
| COMPASS THERAPEUTICS, INC. | Chairman | 01/01/2015 |
| BLOSSOMHILL THERAPEUTICS, INC. | Director/Board Member | 01/02/2021 |
| SCRIBE THERAPEUTICS INC. | Director/Board Member | 01/03/2021 |
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed generally seeks long-term capital appreciation through investments in companies in the global healthcare sector. | Founder | 01/01/1989 |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Director/Board Member | - |
Kumquat Biosciences, Inc.
 Kumquat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Director/Board Member | - |
X4 Pharmaceuticals (Austria) GmbH | Director/Board Member | - |
Gwynant Therapeutics
 Gwynant Therapeutics Pharmaceuticals: MajorHealth Technology Develops novel small molecules for oncology targets | Director/Board Member | - |
Garuda Therapeutics, Inc.
 Garuda Therapeutics, Inc. BiotechnologyHealth Technology Develops hematopoietic stem cell therapies to treat severe and life-threatening diseases | Director/Board Member | - |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of Carl Gordon
| Companies | Position | End |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Training of Carl Gordon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
62
1st degree connections
61
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 61 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Amarin Corp. Plc
 Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
OrbiMed Advisors LLC
OrbiMed Advisors LLC Investment ManagersFinance OrbiMed generally seeks long-term capital appreciation through investments in companies in the global healthcare sector. | Finance |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Arius Research, Inc.
 Arius Research, Inc. BiotechnologyHealth Technology Develops anti-cancer antibodies | Health Technology |
Sapphire Therapeutics, Inc.
 Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Amnis Corp.
 Amnis Corp. BiotechnologyHealth Technology Provides cell imaging and instrument development, manufacturing and marketing services | Health Technology |
Singulex, Inc.
 Singulex, Inc. Medical SpecialtiesHealth Technology Operates as an immunodiagnostics company | Health Technology |
Complete Genomics, Inc.
 Complete Genomics, Inc. BiotechnologyHealth Technology Develops and markets DNA sequencing technology | Health Technology |
Adimab LLC
 Adimab LLC Information Technology ServicesTechnology Services Develops yeast-based antibody discovery technology platform | Technology Services |
Igenica Biotherapeutics, Inc.
 Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
Arsanis, Inc.
 Arsanis, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage structure based drug design company for cancer diseases | Health Technology |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Operates in the healthcare industry focusing on biotechnology business | Health Technology |
Pacira Biosciences, Inc.
 Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Develops medicines for cancers | Commercial Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The New York City Investment Fund Manager, Inc.
 The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager invests in the companies located in the United States. The firm focuses on fintech, health IT, life sciences and advanced manufacturing sectors. It participates in early and growth stage capital transactions. The firm acquires minority interest. | Finance |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Good Start Genetics, Inc.
 Good Start Genetics, Inc. Medical/Nursing ServicesHealth Services Provides molecular diagnostics services | Health Services |
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer | Health Technology |
Alector, Inc.
 Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer | Health Technology |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Health Technology |
X4 Pharmaceuticals (Austria) GmbH | |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Balance Therapeutics, Inc.
 Balance Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for neurological disabilities | Health Technology |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Oric Pharmaceuticals, Inc.
 Oric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceutical products | Health Technology |
Keros Therapeutics, Inc.
 Keros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for muscle diseases | Health Technology |
Gemini Therapeutics Sub, Inc.
 Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops drugs for dry age-related macular degeneration and associated rare genetic diseases | Health Technology |
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for neurodegenerative diseases | Health Technology |
Olivia Ventures, Inc.
 Olivia Ventures, Inc. Financial ConglomeratesFinance Operates as blank check company | Finance |
Theseus Pharmaceuticals, Inc.
 Theseus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and supplies drugs for cancer patients | Health Technology |
Terns Pharmaceuticals, Inc.
 Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Springworks Therapeutics, Inc.
 Springworks Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes medicines for nervous system disorders | Health Technology |
Emendo Biotherapeutics, Inc.
Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Operates genome editing company that develops genetic medicines and cell therapies for severe diseases | Health Technology |
MBX Biosciences, Inc.
 MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders | Health Technology |
Kumquat Biosciences, Inc.
Kumquat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage precision oncology company | Health Technology |
Frontera Therapeutics (HK) Ltd.
 Frontera Therapeutics (HK) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Scribe Therapeutics, Inc.
 Scribe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops CRISPR-based genetic medicines to extend healthy lifespan through disease prevention and durable therapeutic interventions | Health Technology |
Compass Therapeutics, Inc.
 Compass Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology biopharmaceutical company that develops antibody based therapeutics to treat multiple human diseases | Health Technology |
Odyssey Therapeutics, Inc.
 Odyssey Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for autoimmune and inflammatory diseases | Health Technology |
Adicet Bio, Inc.
 Adicet Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development of cell immunotherapies | Health Technology |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for dry age-related macular degeneration and associated rare genetic diseases | Health Technology |
Arrivent BioPharma, Inc.
 Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
Xinthera, Inc.
 Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Produces novel oncology and immunology drugs | Health Technology |
Gwynant Therapeutics
Gwynant Therapeutics Pharmaceuticals: MajorHealth Technology Develops novel small molecules for oncology targets | Health Technology |
Garuda Therapeutics, Inc.
Garuda Therapeutics, Inc. BiotechnologyHealth Technology Develops hematopoietic stem cell therapies to treat severe and life-threatening diseases | Health Technology |
Venetian-1 Acquisition Corp.
 Venetian-1 Acquisition Corp. Pharmaceuticals: MajorHealth Technology Develops medicines for hematological malignancies | Health Technology |
Electra Therapeutics, Inc.
 Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapies for immunological diseases and cancer | Health Technology |
Star Therapeutics, Inc.
 Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies for hematology and immunology problems | Health Technology |
- Stock Market
- Insiders
- Carl Gordon
